BioCentury | Oct 29, 2020
Finance

Perceptive-backed in-licensing play LianBio to cast a wide net with $310M crossover round

...NYSE:PFE), Sphera Healthcare, T. Rowe Price Associates, Tybourne Capital Management...
BioCentury | May 22, 2020
Product Development

May 21 Quick Takes: EC approves Zolgensma for SMA; plus Sunovion, Kadmon, Sorrento, tafasitamab, Zentalis’ new JV

...Shanghai-based joint venture, Zentera Therapeutics Inc., with a $20 million series A round from investors Tybourne Capital Management...
Items per page:
1 - 2 of 2
BioCentury | Oct 29, 2020
Finance

Perceptive-backed in-licensing play LianBio to cast a wide net with $310M crossover round

...NYSE:PFE), Sphera Healthcare, T. Rowe Price Associates, Tybourne Capital Management...
BioCentury | May 22, 2020
Product Development

May 21 Quick Takes: EC approves Zolgensma for SMA; plus Sunovion, Kadmon, Sorrento, tafasitamab, Zentalis’ new JV

...Shanghai-based joint venture, Zentera Therapeutics Inc., with a $20 million series A round from investors Tybourne Capital Management...
Items per page:
1 - 2 of 2